This topic contains a solution. Click here to go to the answer

Author Question: Funding from private industry is a potential source of bias for research because a. IRB approval ... (Read 166 times)

tichca

  • Hero Member
  • *****
  • Posts: 554
Funding from private industry is a potential source of bias for research because
 
  a. IRB approval is not necessary for this research
  b. future funding for research may depend on the results that a psychologist finds
  c. the researchers receive money for their work
  d. sufficient funds are not available from this source to do the work properly

Question 2

The powerful agencies that fund research tend to
 
  a. Direct the topic of research, often to further their own purposes
  b. Limit IRB approval for psychological research
  c. Limit the application process for funding
  d. Prohibit those without a Ph.D from applying for funds



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

fffftttt

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

b

Answer to Question 2

a




tichca

  • Member
  • Posts: 554
Reply 2 on: Jun 20, 2018
:D TYSM


samiel-sayed

  • Member
  • Posts: 337
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

In 1885, the Lloyd Manufacturing Company of Albany, New York, promoted and sold "Cocaine Toothache Drops" at 15 cents per bottle! In 1914, the Harrison Narcotic Act brought the sale and distribution of this drug under federal control.

Did you know?

Children of people with alcoholism are more inclined to drink alcohol or use hard drugs. In fact, they are 400 times more likely to use hard drugs than those who do not have a family history of alcohol addiction.

Did you know?

Atropine was named after the Greek goddess Atropos, the oldest and ugliest of the three sisters known as the Fates, who controlled the destiny of men.

Did you know?

In 1844, Charles Goodyear obtained the first patent for a rubber condom.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

For a complete list of videos, visit our video library